Drug and environmental factors associated with adverse pregnancy outcomes. Part III: Folic acid: pharmacology, therapeutic recommendations, and economics (Q38549352)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 1998

Language	Label	Description	Also known as
English	Drug and environmental factors associated with adverse pregnancy outcomes. Part III: Folic acid: pharmacology, therapeutic recommendations, and economics	scientific article published on October 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

1 reference

Europe PubMed Central

Drug and environmental factors associated with adverse pregnancy outcomes. Part III: Folic acid: pharmacology, therapeutic recommendations, and economics (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

1 reference

based on heuristic

inferred from title

author name string

D P Lewis

1

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

D C Van Dyke

2

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

P J Stumbo

3

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

M J Berg

4

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

language of work or name

0 references

publication date

1 October 1998

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

1087-1095

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Drug and environmental factors associated with adverse pregnancy outcomes. Part II: Improvement with folic acid

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Methionine metabolism in mammals

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Metabolism of sulfur-containing amino acids

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Folate metabolism and neural tube defects: a review

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Homocysteine and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Maternal hyperhomocysteinemia: a risk factor for neural-tube defects?

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Homocysteine metabolism in pregnancies complicated by neural-tube defects

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Hyperhomocysteinemia: a risk factor for placental abruption or infarction

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

The methylfolate axis in neural tube defects: in vitro characterisation and clinical investigation.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Risk of neural tube defect-affected pregnancy is associated with a block in maternal one-carbon metabolism at the level of N-5-methyltetrahydrofolate:homocysteine methyltransferase.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Methionine decreases the embryotoxicity of sodium valproate in the rat: in vivo and in vitro observations

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Long term treatment with betaine in methylenetetrahydrofolate reductase deficiency

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Inositol prevents folate-resistant neural tube defects in the mouse.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Folate and cancer: A review of the literature

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Folic acid as a cancer-preventing agent

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Folates and psychiatric disorders. Clinical potential

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Megaloblastic anaemia due to phenobarbitone; the convulsant action of therapeutic doses of folic acid.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Effects of folic acid on the mental state and fit-frequency of drug-treated epileptic patients.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Folate therapy in epilepsy. A controlled study.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Phenytoin-folic acid interaction

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Screening the Older Population for Cobalamin (Vitamin B12) Deficiency

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Oral cobalamin for treatment of pernicious anemia?

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Zinc status of a group of pregnant adolescents at 36 weeks gestation living in southern Ontario

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Zinc, copper, and nitrogen balances during bed rest and fluoride supplementation in healthy adult males

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Current treatment strategies in selected situations in epilepsy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Folate intake and food sources in the US population

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Minimum effective dose of folic acid for food fortification to prevent neural-tube defects

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Serum Folate and Risk of Fatal Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Folic acid: effect on zinc absorption in humans and in the rat.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Zinc concentration in plasma and erythrocytes of subjects receiving folic acid supplementation

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Are iron-folate supplements harmful?

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Folic acid fortification of grain: an economic analysis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Neural tube defects and elevated homocysteine levels in amniotic fluid

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Maternal and fetal levels of methionine and homocysteine in early human pregnancy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Possible basis for primary prevention of birth defects with folic acid

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Maternal-Fetal Folate Status and Neural Tube Defects: A Case Control Study

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Enzyme defect as a risk factor for spina bifida

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Is the common 677C-->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Is mutated MTHFR a risk factor for neural tube defects?

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Altered folate and vitamin B12 metabolism in families with spina bifida offspring

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Are common mutations of cystathionine beta-synthase involved in the aetiology of neural tube defects?

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Methionine and neural tube closure in cultured rat embryos: morphological and biochemical analyses

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Whole rat embryos require methionine for neural tube closure when cultured on cow serum

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Defective homocysteine metabolism as a risk factor for diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Folic acid fortification of the food supply. Potential benefits and risks for the elderly population

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Influence of folic acid on blood-phenytoin levels

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

A controlled study of folic acid in epilepsy. A controlled study of folic acid in epilepsy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Effects of folic acid on fit-frequency and behaviour in epileptics on anticonvulsants

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Subnormal serum folate due to anticonvulsive therapy. A double-blind study of the effect of folic acid treatment in patients with drug-induced subnormal serum folates

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

The influence of folic acid on the frequency of epileptic attacks

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

The administration of folic acid to institutionalized epileptic adults with phenytoin-induced gingival hyperplasia. A double-blind, randomized, placebo-controlled, parallel study

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Effect of oral folic acid supplements on zinc, copper, and iron absorption and excretion

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Maternal zinc, iron, folic acid, and protein nutriture and outcome of human pregnancy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Postpartum folic acid supplementation of adolescents: impact on maternal folate and zinc status and milk composition

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Intestinal transport of zinc and folic acid: a mutual inhibitory effect

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Neural tube defects and serum zinc

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly (SBA)

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Prevention of neural tube defects

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Prevention of neural-tube defects

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Prevention of neural tube defects

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Minimal compliance with the Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Folate prophylaxis in pregnancy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Folic acid in prevention of neural tube defects

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Folate levels and neural tube defects. Implications for prevention

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Accelerated folate breakdown in pregnancy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.17427

21 January 2018

Identifiers

10.1345/APH.17427

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38549352&oldid=1766773350"